...
首页> 外文期刊>Asian Pacific Journal of Cancer Prevention >Clinical Study on Safety and Efficacy of Qinin sup?/sup (Cantharidin Sodium) Injection Combined with Chemotherapy in Treating Patients with Gastric Cancer
【24h】

Clinical Study on Safety and Efficacy of Qinin sup?/sup (Cantharidin Sodium) Injection Combined with Chemotherapy in Treating Patients with Gastric Cancer

机译:秦宁β(Cantharidin钠)注射液与化疗治疗胃癌患者的临床研究

获取原文
           

摘要

Objectives: To assess the efficacy, side effects, and the impact on quality of life with (Cantharidin sodium) injection combined with chemotherapy for gastric cancer patients. Method: A consecutive cohort of 70 patients were divided into two groups: experimental group with cantharidin sodium injection combined with chemotherapy, while the control group received chemotherapy alone. After more than two courses of treatment, efficacy, quality of life and side effects were evaluated. Results: The response rate of experimental group was not significantly different from that of the control group (P0.05), but differences were significant in clinical benefit response and KPS score. In addition, gastrointestinal reactions and the incidence of leukopenia were lower than in the control group (P (Cantharidin sodium) injection combined with chemotherapy enhances clinical benefit response, improving quality of life of gastric cancer patients and reducing side effects of chemotherapy. Thus (Cantharidin sodium) injection deserves to be further investigated in randomized control clinical trails.
机译:目的:评估疗效,副作用和对胃癌化疗联合胃癌患者的效果,副作用和对生活质量的影响。方法:将70名患者的连续群组分为两组:实验组,具有Cantharidin钠注射液相同化疗,而对照组单独接受化疗。经过两种以上的治疗,疗效,寿命质量和副作用进行了评估。结果:实验组的响应率与对照组的响应率没有显着差异(P> 0.05),但临床效益响应和KPS评分中的差异显着。此外,胃肠道反应和白细胞减少的发病率低于对照组(P(Cantharidin钠)注射液与化疗联合增强临床效益应答,提高胃癌患者的生活质量,降低化疗的副作用。因此(Cantharidin钠)注射值得进一步研究随机对照临床轨迹。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号